[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

EMEA (Europe, Middle East and Africa) NGS-based RNA-seq Market Report 2018

March 2018 | 113 pages | ID: E0CDC4DA231QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA NGS-based RNA-seq market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of NGS-based RNA-seq for these regions, from 2013 to 2025 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA NGS-based RNA-seq market competition by top manufacturers/players, with NGS-based RNA-seq sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Illumina
  • Thermo Fisher Scientific
  • Pacific Biosciences of California
  • QIAGEN
  • BGI
  • Oxford Nanopore Technologies
  • PerkinElmer
  • GATC Biotech
  • Agilent Technologies
  • Roche
  • Macrogen
  • Eurofins Scientific
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • Sample Preparation
  • Sample Preparation, by Method
  • Sequencing Platforms & Consumables for RNA-Seq
  • RNA Sequencing Services
  • Data Analysis, Storage, and Management
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • De Novo Transcriptome Assembly
  • Expression Profiling Analysis
  • Variant Calling and Transcriptome Epigenetics
  • Small RNA Sequencing
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) NGS-based RNA-seq Market Report 2018

1 NGS-BASED RNA-SEQ OVERVIEW

1.1 Product Overview and Scope of NGS-based RNA-seq
1.2 Classification of NGS-based RNA-seq
  1.2.1 EMEA NGS-based RNA-seq Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA NGS-based RNA-seq Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Sample Preparation
  1.2.4 Sample Preparation, by Method
  1.2.5 Sequencing Platforms & Consumables for RNA-Seq
  1.2.6 RNA Sequencing Services
  1.2.7 Data Analysis, Storage, and Management
1.3 EMEA NGS-based RNA-seq Market by Application/End Users
  1.3.1 EMEA NGS-based RNA-seq Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 De Novo Transcriptome Assembly
  1.3.3 Expression Profiling Analysis
  1.3.4 Variant Calling and Transcriptome Epigenetics
  1.3.5 Small RNA Sequencing
1.4 EMEA NGS-based RNA-seq Market by Region
  1.4.1 EMEA NGS-based RNA-seq Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of NGS-based RNA-seq (2013-2025)
  1.5.1 EMEA NGS-based RNA-seq Sales and Growth Rate (2013-2025)
  1.5.2 EMEA NGS-based RNA-seq Revenue and Growth Rate (2013-2025)

2 EMEA NGS-BASED RNA-SEQ COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA NGS-based RNA-seq Market Competition by Players/Manufacturers
  2.1.1 EMEA NGS-based RNA-seq Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA NGS-based RNA-seq Revenue and Share by Players (2013-2018)
  2.1.3 EMEA NGS-based RNA-seq Sale Price by Players (2013-2018)
2.2 EMEA NGS-based RNA-seq (Volume and Value) by Type/Product Category
  2.2.1 EMEA NGS-based RNA-seq Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA NGS-based RNA-seq Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA NGS-based RNA-seq Sale Price by Type (2013-2018)
2.3 EMEA NGS-based RNA-seq (Volume) by Application
2.4 EMEA NGS-based RNA-seq (Volume and Value) by Region
  2.4.1 EMEA NGS-based RNA-seq Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA NGS-based RNA-seq Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA NGS-based RNA-seq Sales Price by Region (2013-2018)

3 EUROPE NGS-BASED RNA-SEQ (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe NGS-based RNA-seq Sales and Value (2013-2018)
  3.1.1 Europe NGS-based RNA-seq Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
3.2 Europe NGS-based RNA-seq Sales and Market Share by Type
3.3 Europe NGS-based RNA-seq Sales and Market Share by Application
3.4 Europe NGS-based RNA-seq Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe NGS-based RNA-seq Sales Volume by Countries (2013-2018)
  3.4.2 Europe NGS-based RNA-seq Revenue by Countries (2013-2018)
  3.4.3 Germany NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  3.4.4 France NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  3.4.5 UK NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  3.4.6 Russia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  3.4.7 Italy NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  3.4.8 Benelux NGS-based RNA-seq Sales and Growth Rate (2013-2018)

4 MIDDLE EAST NGS-BASED RNA-SEQ (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East NGS-based RNA-seq Sales and Value (2013-2018)
  4.1.1 Middle East NGS-based RNA-seq Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
4.2 Middle East NGS-based RNA-seq Sales and Market Share by Type
4.3 Middle East NGS-based RNA-seq Sales and Market Share by Application
4.4 Middle East NGS-based RNA-seq Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East NGS-based RNA-seq Sales Volume by Countries (2013-2018)
  4.4.2 Middle East NGS-based RNA-seq Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  4.4.4 Israel NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  4.4.5 UAE NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  4.4.6 Iran NGS-based RNA-seq Sales and Growth Rate (2013-2018)

5 AFRICA NGS-BASED RNA-SEQ (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa NGS-based RNA-seq Sales and Value (2013-2018)
  5.1.1 Africa NGS-based RNA-seq Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
5.2 Africa NGS-based RNA-seq Sales and Market Share by Type
5.3 Africa NGS-based RNA-seq Sales and Market Share by Application
5.4 Africa NGS-based RNA-seq Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa NGS-based RNA-seq Sales Volume by Countries (2013-2018)
  5.4.2 Africa NGS-based RNA-seq Revenue by Countries (2013-2018)
  5.4.3 South Africa NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  5.4.5 Egypt NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  5.4.6 Algeria NGS-based RNA-seq Sales and Growth Rate (2013-2018)

6 EMEA NGS-BASED RNA-SEQ MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Illumina
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 NGS-based RNA-seq Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Illumina NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Thermo Fisher Scientific
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 NGS-based RNA-seq Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Thermo Fisher Scientific NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pacific Biosciences of California
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 NGS-based RNA-seq Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pacific Biosciences of California NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 QIAGEN
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 NGS-based RNA-seq Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 QIAGEN NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 BGI
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 NGS-based RNA-seq Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 BGI NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Oxford Nanopore Technologies
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 NGS-based RNA-seq Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Oxford Nanopore Technologies NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 PerkinElmer
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 NGS-based RNA-seq Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 PerkinElmer NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 GATC Biotech
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 NGS-based RNA-seq Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 GATC Biotech NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Agilent Technologies
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 NGS-based RNA-seq Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Agilent Technologies NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Roche
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 NGS-based RNA-seq Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Roche NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Macrogen
6.12 Eurofins Scientific

7 NGS-BASED RNA-SEQ MANUFACTURING COST ANALYSIS

7.1 NGS-based RNA-seq Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of NGS-based RNA-seq

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 NGS-based RNA-seq Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of NGS-based RNA-seq Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NGS-BASED RNA-SEQ MARKET FORECAST (2018-2025)

11.1 EMEA NGS-based RNA-seq Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA NGS-based RNA-seq Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA NGS-based RNA-seq Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA NGS-based RNA-seq Price and Trend Forecast (2018-2025)
11.2 EMEA NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA NGS-based RNA-seq Sales Forecast by Type (2018-2025)
11.7 EMEA NGS-based RNA-seq Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of NGS-based RNA-seq
Figure EMEA NGS-based RNA-seq Sales Volume (K Units) by Type (2013-2025)
Figure EMEA NGS-based RNA-seq Sales Volume Market Share by Type (Product Category) in 2017
Figure Sample Preparation Product Picture
Figure Sample Preparation, by Method Product Picture
Figure Sequencing Platforms & Consumables for RNA-Seq Product Picture
Figure RNA Sequencing Services Product Picture
Figure Data Analysis, Storage, and Management Product Picture
Figure EMEA NGS-based RNA-seq Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of NGS-based RNA-seq by Application in 2017
Figure De Novo Transcriptome Assembly Examples
Table Key Downstream Customer in De Novo Transcriptome Assembly
Figure Expression Profiling Analysis Examples
Table Key Downstream Customer in Expression Profiling Analysis
Figure Variant Calling and Transcriptome Epigenetics Examples
Table Key Downstream Customer in Variant Calling and Transcriptome Epigenetics
Figure Small RNA Sequencing Examples
Table Key Downstream Customer in Small RNA Sequencing
Figure EMEA NGS-based RNA-seq Market Size (Million USD) by Region (2013-2025)
Figure Europe NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe NGS-based RNA-seq Revenue (Million USD) Status and Forecast by Countries
Figure Middle East NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East NGS-based RNA-seq Revenue (Million USD) Status and Forecast by Countries
Figure Africa NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa NGS-based RNA-seq Revenue (Million USD) Status and Forecast by Countries
Figure EMEA NGS-based RNA-seq Sales Volume and Growth Rate (2013-2025)
Figure EMEA NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA NGS-based RNA-seq Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA NGS-based RNA-seq Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA NGS-based RNA-seq Sales Share by Players (2013-2018)
Figure 2017 NGS-based RNA-seq Sales Share by Players
Figure 2017 NGS-based RNA-seq Sales Share by Players
Figure EMEA NGS-based RNA-seq Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA NGS-based RNA-seq Revenue (Million USD) by Players (2013-2018)
Table EMEA NGS-based RNA-seq Revenue Share by Players (2013-2018)
Table 2017 EMEA NGS-based RNA-seq Revenue Share by Players
Table 2017 EMEA NGS-based RNA-seq Revenue Share by Players
Table EMEA NGS-based RNA-seq Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA NGS-based RNA-seq Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA NGS-based RNA-seq Sales Share by Type (2013-2018)
Figure Sales Market Share of NGS-based RNA-seq by Type (2013-2018)
Figure EMEA NGS-based RNA-seq Sales Market Share by Type (2013-2018)
Table EMEA NGS-based RNA-seq Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA NGS-based RNA-seq Revenue Share by Type (2013-2018)
Figure Revenue Market Share of NGS-based RNA-seq by Type in 2017
Table EMEA NGS-based RNA-seq Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA NGS-based RNA-seq Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA NGS-based RNA-seq Sales Share by Application (2013-2018)
Figure Sales Market Share of NGS-based RNA-seq by Application (2013-2018)
Figure EMEA NGS-based RNA-seq Sales Market Share by Application in 2017
Table EMEA NGS-based RNA-seq Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA NGS-based RNA-seq Sales Share by Region (2013-2018)
Figure Sales Market Share of NGS-based RNA-seq by Region (2013-2018)
Figure EMEA NGS-based RNA-seq Sales Market Share in 2017
Table EMEA NGS-based RNA-seq Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA NGS-based RNA-seq Revenue Share by Region (2013-2018)
Figure Revenue Market Share of NGS-based RNA-seq by Region (2013-2018)
Figure EMEA NGS-based RNA-seq Revenue Market Share Regions in 2017
Table EMEA NGS-based RNA-seq Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Europe NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
Table Europe NGS-based RNA-seq Sales (K Units) by Type (2013-2018)
Table Europe NGS-based RNA-seq Market Share by Type (2013-2018)
Figure Europe NGS-based RNA-seq Market Share by Type in 2017
Table Europe NGS-based RNA-seq Sales (K Units) by Application (2013-2018)
Table Europe NGS-based RNA-seq Market Share by Application (2013-2018)
Figure Europe NGS-based RNA-seq Market Share by Application in 2017
Table Europe NGS-based RNA-seq Sales (K Units) by Countries (2013-2018)
Table Europe NGS-based RNA-seq Sales Market Share by Countries (2013-2018)
Figure Europe NGS-based RNA-seq Sales Market Share by Countries (2013-2018)
Figure Europe NGS-based RNA-seq Sales Market Share by Countries in 2017
Table Europe NGS-based RNA-seq Revenue (Million USD) by Countries (2013-2018)
Table Europe NGS-based RNA-seq Revenue Market Share by Countries (2013-2018)
Figure Europe NGS-based RNA-seq Revenue Market Share by Countries (2013-2018)
Figure Europe NGS-based RNA-seq Revenue Market Share by Countries in 2017
Figure Germany NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure France NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure UK NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Russia NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Italy NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East NGS-based RNA-seq Sales (K Units) by Type (2013-2018)
Table Middle East NGS-based RNA-seq Market Share by Type (2013-2018)
Figure Middle East NGS-based RNA-seq Market Share by Type (2013-2018)
Table Middle East NGS-based RNA-seq Sales (K Units) by Applications (2013-2018)
Table Middle East NGS-based RNA-seq Market Share by Applications (2013-2018)
Figure Middle East NGS-based RNA-seq Sales Market Share by Application in 2017
Table Middle East NGS-based RNA-seq Sales Volume (K Units) by Countries (2013-2018)
Table Middle East NGS-based RNA-seq Sales Volume Market Share by Countries (2013-2018)
Figure Middle East NGS-based RNA-seq Sales Volume Market Share by Countries in 2017
Table Middle East NGS-based RNA-seq Revenue (Million USD) by Countries (2013-2018)
Table Middle East NGS-based RNA-seq Revenue Market Share by Countries (2013-2018)
Figure Middle East NGS-based RNA-seq Revenue Market Share by Countries (2013-2018)
Figure Middle East NGS-based RNA-seq Revenue Market Share by Countries in 2017
Figure Saudi Arabia NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Israel NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure UAE NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Iran NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Africa NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Africa NGS-based RNA-seq Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa NGS-based RNA-seq Sales (K Units) by Type (2013-2018)
Table Africa NGS-based RNA-seq Sales Market Share by Type (2013-2018)
Figure Africa NGS-based RNA-seq Sales Market Share by Type (2013-2018)
Figure Africa NGS-based RNA-seq Sales Market Share by Type in 2017
Table Africa NGS-based RNA-seq Sales (K Units) by Application (2013-2018)
Table Africa NGS-based RNA-seq Sales Market Share by Application (2013-2018)
Figure Africa NGS-based RNA-seq Sales Market Share by Application (2013-2018)
Table Africa NGS-based RNA-seq Sales Volume (K Units) by Countries (2013-2018)
Table Africa NGS-based RNA-seq Sales Market Share by Countries (2013-2018)
Figure Africa NGS-based RNA-seq Sales Market Share by Countries (2013-2018)
Figure Africa NGS-based RNA-seq Sales Market Share by Countries in 2017
Table Africa NGS-based RNA-seq Revenue (Million USD) by Countries (2013-2018)
Table Africa NGS-based RNA-seq Revenue Market Share by Countries (2013-2018)
Figure Africa NGS-based RNA-seq Revenue Market Share by Countries (2013-2018)
Figure Africa NGS-based RNA-seq Revenue Market Share by Countries in 2017
Figure South Africa NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Table Illumina NGS-based RNA-seq Basic Information List
Table Illumina NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Illumina NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Illumina NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure Illumina NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table Thermo Fisher Scientific NGS-based RNA-seq Basic Information List
Table Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Thermo Fisher Scientific NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Thermo Fisher Scientific NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure Thermo Fisher Scientific NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table Pacific Biosciences of California NGS-based RNA-seq Basic Information List
Table Pacific Biosciences of California NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pacific Biosciences of California NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Pacific Biosciences of California NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure Pacific Biosciences of California NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table QIAGEN NGS-based RNA-seq Basic Information List
Table QIAGEN NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure QIAGEN NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure QIAGEN NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure QIAGEN NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table BGI NGS-based RNA-seq Basic Information List
Table BGI NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BGI NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure BGI NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure BGI NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table Oxford Nanopore Technologies NGS-based RNA-seq Basic Information List
Table Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Oxford Nanopore Technologies NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Oxford Nanopore Technologies NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure Oxford Nanopore Technologies NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table PerkinElmer NGS-based RNA-seq Basic Information List
Table PerkinElmer NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure PerkinElmer NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure PerkinElmer NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure PerkinElmer NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table GATC Biotech NGS-based RNA-seq Basic Information List
Table GATC Biotech NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GATC Biotech NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure GATC Biotech NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure GATC Biotech NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table Agilent Technologies NGS-based RNA-seq Basic Information List
Table Agilent Technologies NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Agilent Technologies NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Agilent Technologies NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure Agilent Technologies NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table Roche NGS-based RNA-seq Basic Information List
Table Roche NGS-based RNA-seq Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche NGS-based RNA-seq Sales (K Units) and Growth Rate (2013-2018)
Figure Roche NGS-based RNA-seq Sales Market Share in EMEA (2013-2018)
Figure Roche NGS-based RNA-seq Revenue Market Share in EMEA (2013-2018)
Table Macrogen NGS-based RNA-seq Basic Information List
Table Eurofins Scientific NGS-based RNA-seq Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of NGS-based RNA-seq
Figure Manufacturing Process Analysis of NGS-based RNA-seq
Figure NGS-based RNA-seq Industrial Chain Analysis
Table Raw Materials Sources of NGS-based RNA-seq Major Manufacturers in 2017
Table Major Buyers of NGS-based RNA-seq
Table Distributors/Traders List
Figure EMEA NGS-based RNA-seq Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA NGS-based RNA-seq Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA NGS-based RNA-seq Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA NGS-based RNA-seq Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA NGS-based RNA-seq Sales Market Share Forecast by Region (2018-2025)
Table EMEA NGS-based RNA-seq Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA NGS-based RNA-seq Revenue Market Share Forecast by Region (2018-2025)
Table Europe NGS-based RNA-seq Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe NGS-based RNA-seq Sales Market Share Forecast by Countries (2018-2025)
Table Europe NGS-based RNA-seq Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe NGS-based RNA-seq Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East NGS-based RNA-seq Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East NGS-based RNA-seq Sales Market Share Forecast by Countries (2018-2025)
Table Middle East NGS-based RNA-seq Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East NGS-based RNA-seq Revenue Market Share Forecast by Countries (2018-2025)
Table Africa NGS-based RNA-seq Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa NGS-based RNA-seq Sales Market Share Forecast by Countries (2018-2025)
Table Africa NGS-based RNA-seq Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa NGS-based RNA-seq Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA NGS-based RNA-seq Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA NGS-based RNA-seq Sales Market Share Forecast by Type (2018-2025)
Table EMEA NGS-based RNA-seq Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA NGS-based RNA-seq Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications